| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Isner Joshua | PRESIDENT | 17800 NORTH 85TH STREET, SCOTTSDALE | /s/ Joshua Isner, by Isaiah Fields, Attorney-in-Fact | 03 Dec 2025 | 0001648518 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXON | Common Stock | Tax liability | $1,018,964 | -1,911 | -0.62% | $533.21 | 304,378 | 01 Dec 2025 | Direct | F1 |
| transaction | AXON | Common Stock | Tax liability | $17,507,950 | -32,835 | -11% | $533.21 | 271,543 | 01 Dec 2025 | Direct | F2 |
| transaction | AXON | Common Stock | Sale | $292,385 | -549 | -0.2% | $532.58 | 270,994 | 03 Dec 2025 | Direct | F3, F4 |
| transaction | AXON | Common Stock | Sale | $205,634 | -385 | -0.14% | $534.11 | 270,609 | 03 Dec 2025 | Direct | F3, F5 |
| transaction | AXON | Common Stock | Sale | $23,031 | -43 | -0.02% | $535.60 | 270,566 | 03 Dec 2025 | Direct | F3, F6 |
| transaction | AXON | Common Stock | Sale | $571,101 | -1,064 | -0.39% | $536.75 | 269,502 | 03 Dec 2025 | Direct | F3, F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Securities disposed represent securities withheld to settle the reporting person's tax liability resulting from the vesting of restricted stock units. |
| F2 | Securities disposed represent securities withheld to settle the reporting person's tax liability arising out of the vesting of the second tranche of restricted stock units granted pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions were determined to have been certified by the issuer's Compensation Committee on March 24, 2025. |
| F3 | This sale, effected pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024, consisted of shares issued upon the settlement of vested restricted stock units. |
| F4 | The transaction was executed in multiple trades at prices ranging from $532.04 to $532.85. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | The transaction was executed in multiple trades at prices ranging from $533.92 to $534.58. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | The transaction was executed in multiple trades at prices ranging from $535.4559 to $535.7763. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | The transaction was executed in multiple trades at prices ranging from $536.69 to $536.75. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |